Key findings Within six months of starting GLP-1 therapy, the rate of hypotensive events increased from 8.7% to 10.2% The increased risk remained significant at 12 months, with hypotensive events rising from 13.6% to 14.3% Adults age 65 and older accounted for 53% of hypotensive events despite representing 37% of the study population Patients with Type 2 diabetes made up 75% of those experiencing hypotensive episodes but only 63% of the overall cohort In secondary analyses, the scientists found that weight loss alone did not explain the increased risk, suggesting other mechanisms of action may be at play Below is a Q&A with study senior author Dr
This paleo and Whole30 recipe is gluten-free, grain-free, and dairy-free
Of all B12 forms, its the most effective one for the treatment of neurological symptoms (numbness, tingling, etc)
Clinical studies on weight loss have proven that people using semaglutide can shed as much as 15% of their body weight when they use it in addition to a healthy diet and exercise
For every-other-day shampoo users : Apply nightly before bed, regardless of wash day